API Manufacturer
Api Manufacturer in India
Following the acquisition of Parabolic Drugs by our Company in 2021, we entered the business of the manufacture and sale of key starting materials, intermediates and APIs, and acquired manufacturing units in Dera Bassi and Lalru in Punjab and Barwala in Haryana, and an R&D centre in Barwala, Haryana. Details of our API units are set out below:
Dera Bassi, Punjab: This unit is dedicated to the production of beta lactams and is equipped with six production blocks. With an annual capacity of 557.00 MT. This unit enables us to carry out complex multistep synthesis processes, meeting the high demand for beta lactam APIs.
Lalru, Punjab: This unit is designed for the synthesis of a wide range of APIs spanning various therapy areas. This unit comprises three production blocks and has an annual production capacity of 180.00 MT. At this unit, we produce APIs across a broad spectrum of therapeutic categories.
Barwala, Haryana: This unit is a specialized small-volume, high-potency API manufacturing unit with an annual production capacity of 0.38 MT. This unit features a kilo lab scale pilot plant for experimental and development purposes and is dedicated to handling high-potency APIs with a high degree of expertise.
Expertise, Capacity, and Quality Assurance
State-of-the-art manufacturing facilities with global reach, capable of producing APIs at scale
Across Beta Lactams And General API In Punjab And Haryana Annual Capacity We have 200+ Customers
Developing and Manufacturing High-Quality APIs
Expertise in diverse methodologies, with a proven track record of developing High Quality APIs.
Facilities for Cephalosporins (Dera Bassi) & General Drugs (Lalru)
Fully Equipped QC Labs with Microbiology Labs
In House Solvent Recovery Facility
Well Established QM Systems
Separate Hazardous Chemical Store Area
Multipurpose/ Dedicated Oral & Sterile Manufacturing Blocks
100% Power Backup
Dedicated Warehouses for RM and FG
Reaction Capabilities - Commitment to Safe and Efficient API Manufacturing
Equipped to handle a wide range of reaction types, including hazardous and high-pressure reactions
* Grignard Reaction * Oxidation Esterification * Reactions * Silylation Reactions * Mannich Reaction * Wittig Reaction * Hydrogenation * Reaction * Sand Meyer Reactions * Friedel Craft Reactions * Amide Coupling * Aldol Condensation Products * Metal Hydride Reduction * Intra molecular Cyclization * Diazotization Reactions * Metal Reductions * Reactions in Cryogenic Reactors * Fischer Indole Synthesis * Pall Knorr Pyrrole Synthesis
Our Expertise in Developing APIs
Extensive experience in developing APIs for various areas, dedicated to meeting the unique needs of our customers
R&D Capabilities: We have development facility in Barwala-Haryana, India. Our strong scientific capabilities in synthetic chemistry, analytical chemistry and process engineering, have helped us build a varied portfolio of small molecule APIs across niche areas including Beta-lactams, Non Beta-lactams, HPAPIs, oral & sterile APIs. This expertise has enabled us to develop a strong portfolio in key therapy areas including Antibiotics/Antibacterials, Anti diabetics, Anti hypertensives, GI, Oncology, Pain management.
Chemical Processes: Our capabilities include multistep synthesis & scale-up. We have the expertise to perform versatile chemical reactions, route scouting, process development and optimization, QBD implementation, solid state characterization, polymorph screening, chiral chemistry & enzyme technology.
Regulatory: Akums Lifesciences has an experienced global regulatory expertise focused on international markets. Our top-class quality and cGMP compliance are designed to ensure our products meet stringent requirements of quality standards all the time. We have a dedicated team for regulatory affairs. Our team of regulatory affairs understands the complex issues associated with regulatory agencies and assists in the approval of each complex API by analyzing the latest regulatory trends, quality requirements through active monitoring and proactive assessment of potential risks. This expertise is supported by our strength in intellectual property and regulatory affairs which helps us consistently meet and exceed regulatory & quality standards.
Our Accreditations for API Manufacturing Excellence
ISO 9001-2015 ISO 14001 - 2015 ISO 45001 - 2018
Manufacturing and R&D Facilities
Manufacturing facilities with advanced capabilities, complemented by dedicated R&D laboratories for continuous innovation.
Dera Bassi, Punjab: This unit is dedicated to the production of beta lactams and is equipped with six production blocks. With an annual capacity of 557.00 MT. This unit enables us to carry out complex multistep synthesis processes, meeting the high demand for beta lactam APIs.
Lalru, Punjab: This unit is designed for the synthesis of a wide range of APIs spanning various therapy areas. This unit comprises three production blocks and has an annual production capacity of 180.00 MT. At this unit, we produce APIs across a broad spectrum of therapeutic categories.
Barwala, Haryana: This unit is a specialized small-volume, high-potency API manufacturing unit with an annual production capacity of 0.38 MT. This unit features a kilo lab scale pilot plant for experimental and development purposes and is dedicated to handling high-potency APIs with a high degree of expertise.
Know More about Our Manufacturing Capabilities
Connect with Abeers API division to explore collaborative opportunities ensuring accessibility to medicines across the globe.
